Pharmaxis (United Kingdom)

The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline

John D. Brannan, Sandra D. Anderson, Clare Perry et al. · Respiratory Research · 2005 · 217 citations · Full text

Particle Aerosolisation and Break-up in Dry Powder Inhalers 1: Evaluation and Modelling of Venturi Effects for Agglomerated Systems

William Wong, David F. Fletcher, Daniela Traini et al. · Pharmaceutical Research · 2010 · 57 citations

Asthma, Aerosol Transport, Allergy +7

PXS-4681A, a Potent and Selective Mechanism-Based Inhibitor of SSAO/VAP-1 with Anti-Inflammatory Effects In Vivo

Jonathan S. Foot, Tin T. Yow, Heidi Schilter et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 48 citations

Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluid

N.E. Miller, Waldemar L. Olszewski, Hiroaki Hattori et al. · American Journal of Physiology-Endocrinology and Metabolism · 2012 · 29 citations

Immunology, Cholesterol Esterification Rate, Hyperlipidemia +17

Pan-lysyl oxidase inhibitor PXS-5505 ameliorates multiple-organ fibrosis by inhibiting collagen crosslinks in rodent models of systemic sclerosis

Yimin Yao, Alison D. Findlay, Jessica Stolp et al. · 2021 · 14 citations · Full text

Ssc Patients, Sclerostin, Lung Inflammation +22